Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
2006 • 1,766 citations
Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States
1997 • 1,628 citations
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
2004 • 1,624 citations
Innate immune sensing and its roots: the story of endotoxin
2003 • 1,316 citations
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
2007 • 1,287 citations
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
2002 • 772 citations
Vaccinations and the Risk of Relapse in Multiple Sclerosis
2001 • 482 citations
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
2007 • 456 citations
Hepatitis B Vaccination and the Risk of Multiple Sclerosis
2001 • 430 citations
Vaccination and autoimmune disease: what is the evidence?
2003 • 351 citations
Consequence or coincidence?
2005 • 252 citations
Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
2005 • 215 citations
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients
2005 • 207 citations
New hepatitis B vaccine formulated with an improved adjuvant system
2007 • 181 citations
Human Papilloma Virus Immunization in Adolescent and Young Adults
2007 • 107 citations
The societal value of universal childhood vaccination
2003 • 40 citations
Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer
2007 • 33 citations
Hepatitis B vaccination and multiple sclerosis: the jury is still out
2005 • 24 citations
Human papillomavirus-16/18 candidate vaccine adjuvanted with AS04 and its impact on the incidence of cervical cancer
2007 • 12 citations
Cited By (0)
No citing papers found in database